Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARE | AMGN | GILD | CELG | VRTX |
| Company | Ultragenyx Pharmaceu | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 43.41 | 273.45 | 67.47 | 108.01 | 402.44 |
| High | 44.00 | 274.35 | 67.90 | 108.59 | 403.88 |
| Low | 42.73 | 267.24 | 65.13 | 107.27 | 393.00 |
| Last | 43.84 | 269.38 | 65.30 | 108.24 | 397.89 |
| Change | -0.44 | -3.63 | -1.78 | +0.11 | -2.87 |
| % Change | -0.99% | -1.33% | -2.65% | +0.10% | -0.72% |
| Volume | 289,827 | 1,093,708 | 10,402,868 | 191,230,496 | 552,485 |
| 20-Day Average Volume | 721,675 | 2,112,438 | 6,589,949 | 16,188,930 | 951,523 |
| Previous Close | 44.28 | 273.01 | 67.08 | 108.13 | 400.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 46.32 | 270.73 | 68.68 | 108.17 | 402.32 |
| 20-Day Raw Stochastic | 22.02% | 33.17% | 0.58% | 63.25% | 23.06% |
| 20-Day Relative Strength | 43.28% | 45.28% | 28.27% | 64.69% | 42.91% |
| Weighted Alpha | -0.10 | +9.43 | -23.76 | +46.30 | +15.00 |
| Today's Opinion | 8% Buy | 72% Sell | 100% Sell | 100% Buy | 8% Buy |
| Previous Opinion | 24% Buy | 40% Sell | 100% Sell | 100% Buy | 8% Buy |
| Last Month's Opinion | 56% Buy | 24% Buy | 88% Sell | 100% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.51% since 04/18/24 | +2.73% since 04/18/24 | -1.38% since 04/18/24 | -1.97% since 11/13/19 | +1.16% since 04/18/24 |
| Low | 41.07 on 04/19/24 | 260.68 on 04/19/24 | 65.20 on 04/25/24 | 107.27 on 11/20/19 | 391.25 on 04/19/24 |
| High | 45.58 on 04/23/24 | 274.86 on 04/24/24 | 67.78 on 04/25/24 | 110.53 on 11/14/19 | 406.86 on 04/23/24 |
| 1-Month | |||||
| %Chg | -4.01% since 03/25/24 | -3.88% since 03/25/24 | -10.10% since 03/25/24 | +5.14% since 10/18/19 | -4.33% since 03/25/24 |
| Low | 41.07 on 04/19/24 | 260.68 on 04/19/24 | 65.20 on 04/25/24 | 102.40 on 10/21/19 | 391.01 on 04/18/24 |
| High | 52.56 on 04/11/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 110.70 on 11/13/19 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -3.65% since 01/25/24 | -13.00% since 01/25/24 | -18.67% since 01/25/24 | +13.63% since 08/20/19 | -7.43% since 01/25/24 |
| Low | 41.07 on 04/19/24 | 260.68 on 04/19/24 | 65.20 on 04/25/24 | 93.41 on 08/23/19 | 391.01 on 04/18/24 |
| High | 54.56 on 03/01/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +32.81% since 10/25/23 | -0.82% since 10/25/23 | -16.76% since 10/25/23 | +14.14% since 05/20/19 | +9.64% since 10/25/23 |
| Low | 32.55 on 10/27/23 | 249.70 on 10/31/23 | 65.20 on 04/25/24 | 89.08 on 07/23/19 | 341.90 on 11/16/23 |
| High | 54.56 on 03/01/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,644,244 | 146,436,016 | 83,519,768 | 77,035,920 | 103,580,040 |
| Shares Outstanding, K | 82,300 | 536,376 | 1,245,077 | 711,714 | 258,459 |
| Annual Sales | 434,250,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 9,869,200,000 |
| Annual Net Income | -606,640,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | 3,619,600,000 |
| Last Quarter Sales | 127,390,000 | 8,196,000,000 | 7,114,000,000 | 4,520,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -123,190,000 | 767,000,000 | 1,429,000,000 | 1,691,000,000 | 968,800,000 |
| 60-Month Beta | 0.65 | 0.58 | 0.19 | 1.41 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.52 on 02/15/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.99 on 10/31/19 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/06/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.67 | 9.97 | 10.99 | 30.13 |